Logo 1 Logo 2

Clinical Trial Details

Trial ID: L5921
Source ID: NCT00349362
Associated Drug: Testosterone
Title: Testosterone for Men With Insulin Treated Type 2 Diabetes
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Hypogonadism|Diabetes
Interventions: DRUG: Testosterone|DRUG: 0.9% saline
Outcome Measures: Primary: The effect of 6 months of testosterone replacement on diabetes control measured by HbA1c in hypogonadal men with type 2 diabetes treated with insulin., 6 months | Secondary: The effect of testosterone on ultrasound measured intima-media thickness of the common carotid artery in the study population, 6 months|The effect of testosterone on male hypogonadism as assessed by the Ageing Males Symptoms (AMS), 6 months|The effect of testosterone on markers of vascular risk; blood pressure, serum lipid levels, weight, waist circumference, body fat percentage,, 6 months|urinary micro-albumin, tumour necrosis factor alpha, and highly sensitive C reactive protein levels in the study population., 6 months|The effect of the CAG repeat polymorphism in exon 1 of the androgen receptor gene on the response of the study population to testosterone., 6 months
Sponsor/Collaborators: Sponsor: Barnsley Hospital
Gender: MALE
Age: ADULT, OLDER_ADULT
Phases: PHASE4
Enrollment: 40
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
Start Date: 2006-07
Completion Date: 2008-10
Results First Posted:
Last Update Posted: 2010-03-30
Locations: Barnsley Hospital NHS Foundation Trust, Barnsley, South Yorkshire, S75 2EP, United Kingdom
URL: https://clinicaltrials.gov/show/NCT00349362